Atle Fund Management AB - Stock Holdings in 13F Filings (SEC)
Updated on March 15, 2026.
Based on 13F Filings filed with the SEC on February 6, 2026, for the 2025 Q4 period, Atle Fund Management AB held in its portfolio 39 assets valued at $313,442,282 (i.e. $313.44M).
The most valuable assets in the portfolio included: Eli Lilly & Co ($33.46M), AbbVie Inc ($24.72M), and Merck & Co. Inc ($20.61M).
The chart below shows the top 10 valuable assets, and the table below shows the top 39 valuable assets.
You can see similar for other investment managers.
Related Topics: SEC Topic List.
Data Source: SEC.
Atle Fund Management AB - Stock Holdings in 13F Filings (SEC)
Items per page:
25
0 of 0
| Name of Issuer | No. of Shares | Value ($) | Class |
|---|---|---|---|
| Eli Lilly & Co | 31133 | 33458012 | COM |
| AbbVie Inc | 108181 | 24718276 | COM |
| Merck & Co. Inc | 195768 | 20606539 | COM |
| Thermo Fisher Scientific Corp | 29915 | 17334246 | COM |
| Neurocrine Biosciences Inc | 94796 | 13444916 | COM |
| Intuitive Surgical Inc | 22322 | 12642287 | COM NEW |
| BEONE MEDICINES LTD-ADR | 40432 | 12283645 | SPONSORED ADS |
| Bridgebio Pharma Inc | 141296 | 10807731 | COM |
| Vertex Pharmaceuticals Inc | 22984 | 10420026 | COM |
| Boston Scientific Corp | 108682 | 10362828 | COM |
| Stryker Corporation | 26835 | 9431697 | COM |
| CVS HEALTH CORP | 106518 | 8453268 | COM |
| Krystal Biotech, Inc | 33853 | 8346118 | COM |
| Cencora Inc | 23773 | 8029330 | COM |
| IONIS PHARMACEUTICALS INC | 92377 | 7307944 | COM |
| REVOLUTION Medicines Inc | 90184 | 7183155 | COM |
| Amgen Inc | 21903 | 7169070 | COM |
| Mirum Pharmaceuticals Inc | 89685 | 7084218 | COM |
| INCYTE CORP | 70851 | 6997953 | COM |
| NewAmsterdam Pharma Co NV | 197036 | 6912022 | ORDINARY SHARES |
| Alkermes PLC | 242473 | 6784394 | SHS |
| iRhythm Technologies Inc | 37579 | 6668017 | COM |
| Gilead Sciences Inc | 50796 | 6234701 | COM |
| UFP Technologies Inc | 22986 | 5103581 | COM |
| INSMED INC | 27873 | 4851016 | COM PAR $.01 |
| Cardinal Health Inc | 23470 | 4823085 | COM |
| ABIVAX SA | 31590 | 4260069 | SPONSORED ADS |
| CELCUITY INC | 41831 | 4172223 | COM |
| Disc medicine inc | 47967 | 3809059 | COM |
| IDEAYA BIOSCIENCES INC | 97438 | 3368431 | COM |
| Universal Health Services Inc | 14636 | 3190940 | COM |
| COMPASS THERAPEUTICS INC | 584332 | 3137862 | COM |
| Soleno Therapeutics Inc | 62735 | 2904630 | COM |
| Arcellx Inc | 41717 | 2719948 | COMMON STOCK |
| Dexcom Inc | 39722 | 2636349 | COM NEW |
| Autolus Therapeutics PLC | 1169634 | 2327571 | SPON ADS |
| BICARA THERAPEUTICS INC | 111363 | 1874239 | COM |
| Corbus Pharmaceuticals Holding | 107255 | 873055 | COM |
| PYXIS ONCOLOGY INC | 617245 | 709831 | COMMON STOCK |